Results 211 to 220 of about 50,758 (257)
Some of the next articles are maybe not open access.
Journal of the American Society of Nephrology, 2023
Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2023_04_24_JASN0000000000000078.mp3
openaire +2 more sources
Podcast This article contains a podcast at https://dts.podtrac.com/redirect.mp3/www.asn-online.org/media/podcast/JASN/2023_04_24_JASN0000000000000078.mp3
openaire +2 more sources
American Journal of Kidney Diseases, 2003
Hyperhomocysteinemia is an independent cardiovascular risk factor that possibly accounts for about one of 5 cardiovascular deaths. It is conceivable that the importance of hyperhomocysteinemia will increase when other risk factors, such as hypertension or hypercholesterolemia, will become less prevalent in the general population.
PERNA, Alessandra +6 more
openaire +2 more sources
Hyperhomocysteinemia is an independent cardiovascular risk factor that possibly accounts for about one of 5 cardiovascular deaths. It is conceivable that the importance of hyperhomocysteinemia will increase when other risk factors, such as hypertension or hypercholesterolemia, will become less prevalent in the general population.
PERNA, Alessandra +6 more
openaire +2 more sources
Annals of Internal Medicine, 1978
Excerpt Among the many neurologic complications of the uremic syndrome, abnormalities of behavior and cerebral function are usually discernible early.
T I, Steinman, H M, Yager
openaire +2 more sources
Excerpt Among the many neurologic complications of the uremic syndrome, abnormalities of behavior and cerebral function are usually discernible early.
T I, Steinman, H M, Yager
openaire +2 more sources
Nephron, 1981
Peripheral and bone marrow eosinophils were determined in a group of patients on chronic hemodialysis and in predialysis uremics. Healthy subjects were taken as controls. Increased number of eosinophils in bone marrow were found in the predialysis uremic group and this finding was even more accentuated in the dialyzed patients.
D, Gabizon +4 more
openaire +2 more sources
Peripheral and bone marrow eosinophils were determined in a group of patients on chronic hemodialysis and in predialysis uremics. Healthy subjects were taken as controls. Increased number of eosinophils in bone marrow were found in the predialysis uremic group and this finding was even more accentuated in the dialyzed patients.
D, Gabizon +4 more
openaire +2 more sources
1984
Myopathy of uremia has to some extent been a Cinderella of clinical nephrology. It is widely overlooked because signs and symptoms are usually discrete: easy fatiguability and asthenia, difficulty in performing acts involving tonic contractions of shoulder or pelvic girdles, e.g.
E, Ritz +3 more
openaire +2 more sources
Myopathy of uremia has to some extent been a Cinderella of clinical nephrology. It is widely overlooked because signs and symptoms are usually discrete: easy fatiguability and asthenia, difficulty in performing acts involving tonic contractions of shoulder or pelvic girdles, e.g.
E, Ritz +3 more
openaire +2 more sources
ChemInform, 2005
AbstractFor Abstract see ChemInform Abstract in Full Text.
FLOCCARI F +8 more
openaire +3 more sources
AbstractFor Abstract see ChemInform Abstract in Full Text.
FLOCCARI F +8 more
openaire +3 more sources
Archives of Internal Medicine, 1970
Anemia is an almost invariable part of the uremic syndrome. The majority of patients have a hemolytic component which is extracorpuscular and unrelated to immune mechanisms or splenic sequestration. In some cases mechanical injury due to abnormalities of vasculature may play a role.
openaire +2 more sources
Anemia is an almost invariable part of the uremic syndrome. The majority of patients have a hemolytic component which is extracorpuscular and unrelated to immune mechanisms or splenic sequestration. In some cases mechanical injury due to abnormalities of vasculature may play a role.
openaire +2 more sources
1987
PAs are intracellular regulators of growth and anabolic processes. Toxic properties of PAs are conferred according to the increasing number of cationic charges. In uremia, PA accumulation occurs both in and outside the cell. Decreased PA synthesis and blunted PA pathway responses suggest PAs may participate in cellular down regulation.
openaire +2 more sources
PAs are intracellular regulators of growth and anabolic processes. Toxic properties of PAs are conferred according to the increasing number of cationic charges. In uremia, PA accumulation occurs both in and outside the cell. Decreased PA synthesis and blunted PA pathway responses suggest PAs may participate in cellular down regulation.
openaire +2 more sources